The aerobic oxidation of alkenes to carbonyls is an important and challenging transformation in synthesis. Recently, a new P450-based enzyme (aMOx) has been evolved in the laboratory to directly oxidize styrenes to their corresponding aldehydes with high activity and selectivity. The enzyme utilizes a heme-based, high-valent iron-oxo species as a catalytic oxidant that normally epoxidizes alkenes, similar to other catalysts. How the evolved aMOx enzyme suppresses the commonly preferred epoxidation and catalyzes direct carbonyl formation is currently not well understood. Here, we combine computational modelling together with mechanistic experiments to study the reaction mechanism and unravel the molecular basis behind the selectivity achieved by aMOx. Our results describe that although both pathways are energetically accessible diverging from a common covalent radical intermediate, intrinsic dynamic ef fects determine the strong preference for epoxidation. We discovered that aMOx overrides these intrinsic preferences by controlling the accessible conformations of the covalent radical intermediate. This disfavors epoxidation and facilitates the formation of a carbocation intermediate that generates the aldehyde product through a fast 1,2hydride migration. Electrostatic preorganization of the enzyme active site also contributes to the stabilization of the carbocation intermediate. Computations predicted that the hydride migration is stereoselective due to the enzymatic conformational control over the intermediate species. These predictions were corroborated by experiments using deuterated styrene substrates, which proved that the hydride migration is cis-and enantioselective. Our results demonstrate that directed evolution tailored a highly specific active site that imposes strong steric control over key fleeting biocatalytic intermediates, which is essential for accessing the carbonyl forming pathway and preventing competing epoxidation.
Controlling regio-
and stereoselectivity of aldol additions is
generally challenging. Here we show that an artificial aldolase with
high specificity for acetone as the aldol donor can be reengineered
via single active site mutations to accept linear and cyclic aliphatic
ketones with notable efficiency, regioselectivity, and stereocontrol.
Biochemical and crystallographic data show how the mutated residues
modulate the binding and activation of specific aldol donors, as well
as their subsequent reaction with diverse aldehyde acceptors. Broadening
the substrate scope of this evolutionarily naïve catalyst proved
much easier than previous attempts to redesign natural aldolases,
suggesting that such proteins may be excellent starting points for
the development of customized biocatalysts for diverse practical applications.
Studies
are described toward the synthesis of an oxazole-based
analog of (−)-zampanolide (2). Construction of
(−)-dactylolide analog 22 was achieved via alcohol 5 and acid 4 through esterification and Horner–Wadsworth–Emmons
(HWE)-based macrocyclization; however, attempts to attach (Z,E)-sorbamide to 22 proved
unsuccessful. The C(8)–C(9) double bond of the macrocycle was
prone to migration into conjugation with the oxazole ring, which may
generally limit the usefulness of zampanolide analogs with aromatic
moieties as tetrahydropyran replacements.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.